Category: Emerging MarketsSyndicate content

Abbott closes 3 clinical trials for disappearing drug-eluting coronary stent

April 10, 2014 by Arezu Sarvestani

Healthcare giant Abbott completes enrollment in 3 clinical trials evaluating its novel dissolving, drug-eluting scaffold in patients with blocked heart vessels.

Abbott closes 3 clinical trials of dissappearing drug-eluting stents

Illinois healthcare titan Abbott (NYSE:ABT) closed 3 clinical trials after enrolling about 2,800 patients in studies of the company's dissolving Absorb drug-eluting scaffold.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Emerging medtech margins: Don't think price, think COGS

April 9, 2014 by MassDevice

The prices of medical devices, whether innovative or commodity, are under significant pressure from all corners and in all parts of the globe, and will continue to be for the foreseeable future.

By Tim Kofol, S2N Health

Boston Scientific makes new friends in Israel

April 9, 2014 by Arezu Sarvestani

Medtech titan Boston Scientific plans to sell a slew of its products in Israel through a partnership with distributor Amos Gazit Ltd and marketing group Medison.

Boston Scientifics makes new friends in Israel

Massachusetts medical device maker Boston Scientific (NYSE:BSX) has a new partner in Israel, agreeing to supply a slate of its products through local distributor Amos Gazit Ltd

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Boston Scientific's lead-free S-ICD heads to Asia

April 8, 2014 by Arezu Sarvestani

Boston Scientific's novel lead-free implantable cardioverter defibrillator makes an introduction in the Asia Pacific region.

Boston Scientific's lead-free S-ICD tours Asia

Massachusetts medical device giant Boston Scientific (NYSE:BSX) is taking its S-ICD lead-free cardiac implant on tour, reaching new regions in Asia Pacific.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic puts fresh skin in distribution deals in Turkey and Missouri

April 7, 2014 by Arezu Sarvestani

Medtech titan Medtronic acquires a controlling stake in Turkish distributor Biostar and pens a new deal to sell Kogent Medical's neurosurgery devices.

Medtronic puts fresh skin in distribution deals

Minnesota medical device giant Medtronic (NYSE:MDT) penned a couple of new distribution deals, giving it a controlling stake in a Turkish distributor and expanded access to a Missouri surgical instruments supplier.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp